This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Prime Therapeutics Names Glen Laschober As Chief Operating Officer

ST. PAUL, Minn., April 8, 2013 /PRNewswire/ --  Prime Therapeutics (Prime), a leading pharmacy benefit manager, announced today that it has appointed Glen Laschober as chief operating officer. Laschober will be responsible for developing and implementing the strategic direction for the day-to-day operations of Prime. He will oversee pharmacy benefit management and service operations, information technology, enterprise project planning, and reporting analytics.

"Glen is a seasoned and trusted leader who consistently delivers results," said Eric Elliott, president and CEO at Prime Therapeutics. "I have tremendous confidence in Glen's ability to drive operational excellence across the company and support our continued growth."

Laschober brings to Prime substantial expertise in the health care industry and areas relevant to Prime's strategic growth, specifically specialty pharmacy management. Laschober served as vice president and chief operations officer at US Oncology, the nation's largest oncology company, and Omnicare, a Fortune 500 pharmacy and health care provider. Laschober also held various senior leadership roles at CVS Caremark, Wellinx and ProVantage.

Mostly recently, Laschober was President and CEO at Concorde Career College, where he was instrumental in increasing market revenue and earnings growth.  

Laschober earned his Bachelor of Science in Industrial and Manufacturing Engineering from the University of Illinois and his Masters in Business Administration from the University of Chicago.

About Prime Therapeutics Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Headquartered in St. Paul, Minn., Prime serves nearly 20 million people. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Prime has been recognized as one of the fastest-growing private companies in the nation.

For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.

SOURCE Prime Therapeutics

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,067.83 -58.29 -0.32%
S&P 500 2,114.89 -5.90 -0.28%
NASDAQ 5,082.84 -15.1360 -0.30%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs